Chapter 24: Emerging Infectious Diseases
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Emerging infectious diseases are newly identified pathogens or established microorganisms that have undergone significant changes and demonstrate increasing incidence rates within populations, exemplified by conditions such as HIV/AIDS, Ebola virus disease, and severe acute respiratory syndrome. Reemerging infectious diseases refer to previously controlled pathogens that have resurged, including tuberculosis and malaria, often due to breakdown in containment measures or development of drug resistance. The historical narrative demonstrates how major scientific breakthroughs in vaccination and antimicrobial discovery created a false sense that infectious diseases had been defeated, causing pharmaceutical innovation to shift away from antimicrobial development and creating vulnerability to new threats. The emergence process fundamentally involves pathogen introduction into naive host populations followed by establishment and dissemination, accelerated by multiple interconnected factors. Rapid urbanization concentrates human populations, facilitating pathogen transmission, while global travel and trade networks enable swift spread of both pathogens and disease vectors across continents. Ecological disruption and agricultural expansion expose humans to previously unknown zoonotic reservoirs, and technological innovations in food processing inadvertently create new contamination risks. Microbial evolutionary adaptation operates through antigenic drift, producing minor surface protein variations that allow immune evasion, and antigenic shift, involving major genetic recombination between viral strains to generate novel pathogens. Public health infrastructure deterioration, including compromised sanitation systems and vaccine hesitancy driven by scientific misinformation, permits disease reemergence. The classification framework distinguishes newly recognized pathogens from reemerging diseases and potential bioterrorism agents. Effective response requires coordinated surveillance systems detecting unusual disease clusters, rapid pathogen identification and transmission analysis, and implementation of containment strategies including vaccination, vector management, and quarantine protocols. International collaboration through organizations like the CDC's International Emerging Infections Program and the International Health Regulations framework creates interconnected prevention and detection networks essential for managing public health emergencies transcending national borders.